Sanofi to Buy Dynavax to Boost Vaccines Business

Sanofi is set to acquire Dynavax Technologies, a biotechnology company, in a move to strengthen its vaccine development and manufacturing capabilities. This acquisition is expected to provide Sanofi with Dynavax's adjuvant technology, which could enhance the efficacy and broaden the reach of its existing and future vaccine pipeline.